CAPR position history
The shares of Capricor Therapeutics (CAPR) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q4: 226,304 shares, $6.5M, 0.91% of portfolio, New
- 2026 Q1: 229,763 shares, $7M, 1.1% of portfolio, Add +1.5%
- 2026 Q2: 229,763 shares, $5.5M, 0.76% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|